Spotlight On Zhejiang XCC GroupLtd And Two Other Insider-Favored Growth Leaders

As global markets experience a resurgence, with U.S. stocks climbing on cooling inflation and strong bank earnings, investors are increasingly turning their attention to growth companies with substantial insider ownership. In this environment of cautious optimism, firms like Zhejiang XCC Group Ltd stand out as potential leaders due to their alignment of interests between insiders and shareholders, which can be particularly appealing when navigating the complexities of current market conditions.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Duc Giang Chemicals Group (HOSE:DGC)	31.4%	23.8%
Seojin SystemLtd (KOSDAQ:A178320)	32%	39.9%
Archean Chemical Industries (NSEI:ACI)	22.9%	41.2%
SKS Technologies Group (ASX:SKS)	29.7%	24.8%
Laopu Gold (SEHK:6181)	36.4%	36.1%
Medley (TSE:4480)	34.1%	27.2%
Brightstar Resources (ASX:BTR)	16.2%	84.1%
Fine M-TecLTD (KOSDAQ:A441270)	17.2%	135%
HANA Micron (KOSDAQ:A067310)	18.3%	108.3%
People & Technology (KOSDAQ:A137400)	16.4%	22.5%

Click here to see the full list of 1462 stocks from our Fast Growing Companies With High Insider Ownership screener.

We're going to check out a few of the best picks from our screener tool.

Zhejiang XCC GroupLtd (SHSE:603667)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Zhejiang XCC Group Co., Ltd is involved in the research, development, manufacture, and sale of bearings across the United States, Japan, Korea, Brazil, and other international markets with a market cap of CN¥16.18 billion.

Operations: The company generates revenue through the research, development, manufacturing, and sales of bearings in various international markets including the United States, Japan, Korea, and Brazil.

Insider Ownership: 31.7%

Revenue Growth Forecast: 14.2% p.a.

Zhejiang XCC Group Ltd. shows promising growth potential with earnings forecasted to grow significantly at 28.5% annually, outpacing the Chinese market's 25.2%. However, revenue growth is expected at a slower pace of 14.2% per year compared to the desired threshold of 20%. Despite recent earnings declines and volatile share prices, insider ownership remains high with no substantial insider trading activity noted in the last three months, suggesting confidence in long-term prospects.

• Click here to discover the nuances of Zhejiang XCC GroupLtd with our detailed analytical future growth report.
• Insights from our recent valuation report point to the potential overvaluation of Zhejiang XCC GroupLtd shares in the market.

Shenzhen New Industries Biomedical Engineering (SZSE:300832)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Shenzhen New Industries Biomedical Engineering Co., Ltd. focuses on the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents for hospitals both in China and internationally, with a market cap of CN¥50.05 billion.

Operations: The company generates revenue from the sale of in vitro diagnostic products, amounting to CN¥4.44 billion.

Insider Ownership: 21.8%

Revenue Growth Forecast: 21.2% p.a.

Shenzhen New Industries Biomedical Engineering's revenue is projected to grow at 21.2% annually, surpassing the Chinese market's 13.4%. Despite an unstable dividend history, its earnings are expected to increase significantly over the next three years. Recent financials show a rise in sales to CNY 3.41 billion and net income of CNY 1.38 billion for the nine months ending September 2024, indicating robust growth momentum without substantial insider trading activity noted recently.

• Unlock comprehensive insights into our analysis of Shenzhen New Industries Biomedical Engineering stock in this growth report.
• The valuation report we've compiled suggests that Shenzhen New Industries Biomedical Engineering's current price could be quite moderate.

Kotobuki Spirits (TSE:2222)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Kotobuki Spirits Co., Ltd. is a Japanese company that produces and sells sweets, with a market cap of ¥354.40 billion.

Operations: The company's revenue segments include Shukrei at ¥27.89 billion, Kujukushima at ¥6.75 billion, KCC Co., Ltd. at ¥19.67 billion, Sales Subsidiaries at ¥7.15 billion, and Kotobuki Confectionery/Tajima Kotobuki at ¥13.87 billion.

Insider Ownership: 29.4%

Revenue Growth Forecast: 12.5% p.a.

Kotobuki Spirits forecasts a 15.3% annual earnings growth, outpacing the Japanese market's 8%. Revenue is expected to grow at 12.5% annually, also exceeding market averages. The company trades at a significant discount to its estimated fair value and recently announced a share buyback of ¥3 billion alongside a follow-on equity offering of over 2.58 million shares, aiming to enhance shareholder returns and capital efficiency amidst stable insider ownership levels.

• Click to explore a detailed breakdown of our findings in Kotobuki Spirits' earnings growth report.
• The analysis detailed in our Kotobuki Spirits valuation report hints at an inflated share price compared to its estimated value.

Make It Happen

• Delve into our full catalog of 1462 Fast Growing Companies With High Insider Ownership here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com